Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00464698 · ClinicalTrials.gov registry record · Phase 4
Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00464698: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT00464698 is a Phase 4 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00464698, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy of Duloxetine in the treatment of obsessive compulsive disorder.
Interventions
- DRUG Duloxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-12 |
| Est. Completion | 2013-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00464698
The ClinicalTrials.gov registry entry for NCT00464698 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Duloxetine is the first listed.
NCT00464698 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00464698 about?
NCT00464698 is a clinical study titled "Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)". The purpose of this study is to assess the efficacy of Duloxetine in the treatment of obsessive compulsive disorder.
What is the current status of trial NCT00464698?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2005-12. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00464698?
The interventions under investigation include: Duloxetine (DRUG).
Who is sponsoring clinical trial NCT00464698?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.